releases

Vanderbilt develops new tuberculosis vaccine

A Vanderbilt-led team of researchers has developed a new vaccine technology that may prevent the spread of tuberculosis, which kills more than two million people worldwide each year.

Nancy Andreasen Receives First Annual Vanderbilt Prize

Nancy Andreasen, M.D., Ph.D., a professor of Psychiatry at the University of Iowa, has been selected as the first recipient of the “Vanderbilt Prize in Biomedical Science.”

Vanderbilt Medical Center Opposes Repeal of State’s Motorcycle Helmet Law

Tennessee’s Legislature is again seriously considering a repeal of the state’s mandatory motorcycle helmet law for adults.

Vanderbilt Celebrates National Medical Laboratory Professionals Week

Vanderbilt Medical Center laboratories will be joining the many laboratories across the country that observe and celebrate National Medical Laboratory Professionals Week (NMLPW).

Nationwide Breast Cancer Prevention Trial Resuts

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant

Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.

1 40 41 42 43 44 59